
Over the last 7 days, the Life Sciences industry has dropped 11%, driven by Immuno-Biological Laboratories declining 43%. Meanwhile, Shin Nippon Biomedical Laboratories actually outperformed within the industry, gaining 9.0% in the last week. The industry has fallen 3.5% in the last year. Earnings are forecast to grow by 6.0% annually.
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 10 Dec 2025 | JP¥160.3b | JP¥67.6b | JP¥702.4m | 18.3x | 228.2x | 2.4x |
| Fri, 07 Nov 2025 | JP¥133.0b | JP¥66.5b | JP¥1.5b | 15.6x | 91.1x | 2x |
| Sun, 05 Oct 2025 | JP¥143.6b | JP¥66.5b | JP¥1.5b | 16.6x | 98.4x | 2.2x |
| Tue, 02 Sep 2025 | JP¥149.3b | JP¥66.5b | JP¥1.5b | 16.7x | 102.3x | 2.2x |
| Thu, 31 Jul 2025 | JP¥141.4b | JP¥66.0b | JP¥1.1b | 16.5x | 125.3x | 2.1x |
| Sat, 28 Jun 2025 | JP¥140.7b | JP¥66.0b | JP¥1.1b | 16.3x | 124.5x | 2.1x |
| Mon, 26 May 2025 | JP¥131.8b | JP¥66.0b | JP¥1.1b | 16.5x | 116.3x | 2x |
| Wed, 23 Apr 2025 | JP¥131.4b | JP¥63.8b | JP¥963.0m | 14.1x | 136.5x | 2.1x |
| Fri, 21 Mar 2025 | JP¥162.4b | JP¥64.8b | JP¥927.4m | 15.5x | 175.1x | 2.5x |
| Sun, 16 Feb 2025 | JP¥168.8b | JP¥65.3b | JP¥1.0b | 14.8x | 168.5x | 2.6x |
| Tue, 14 Jan 2025 | JP¥164.8b | JP¥62.0b | JP¥440.7m | 17.8x | 373.9x | 2.7x |
| Thu, 12 Dec 2024 | JP¥162.3b | JP¥62.0b | JP¥825.9m | 17x | 196.6x | 2.6x |
| Sat, 09 Nov 2024 | JP¥157.9b | JP¥62.3b | JP¥1.5b | 20.9x | 108.4x | 2.5x |
| Mon, 07 Oct 2024 | JP¥155.6b | JP¥61.5b | JP¥1.8b | 18.2x | 84.5x | 2.5x |
| Wed, 04 Sep 2024 | JP¥164.4b | JP¥61.5b | JP¥2.1b | 20x | 77.9x | 2.7x |
| Fri, 02 Aug 2024 | JP¥160.6b | JP¥61.8b | JP¥3.2b | 23.9x | 49.6x | 2.6x |
| Sun, 30 Jun 2024 | JP¥168.9b | JP¥61.8b | JP¥3.2b | 26.7x | 52.2x | 2.7x |
| Tue, 28 May 2024 | JP¥162.6b | JP¥61.8b | JP¥3.4b | 24.9x | 48.5x | 2.6x |
| Thu, 25 Apr 2024 | JP¥180.0b | JP¥62.3b | JP¥3.3b | 14.1x | 54.7x | 2.9x |
| Sat, 23 Mar 2024 | JP¥232.5b | JP¥155.4b | JP¥8.6b | 14x | 27x | 1.5x |
| Mon, 19 Feb 2024 | JP¥229.3b | JP¥155.3b | JP¥8.7b | 14.6x | 26.4x | 1.5x |
| Wed, 17 Jan 2024 | JP¥236.1b | JP¥167.1b | JP¥8.5b | 15.7x | 27.8x | 1.4x |
| Fri, 15 Dec 2023 | JP¥231.7b | JP¥167.4b | JP¥8.7b | 14.5x | 26.7x | 1.4x |
| Sun, 12 Nov 2023 | JP¥236.0b | JP¥168.2b | JP¥9.1b | 14.5x | 25.9x | 1.4x |
| Tue, 10 Oct 2023 | JP¥239.8b | JP¥179.3b | JP¥12.8b | 15.1x | 18.8x | 1.3x |
| Thu, 07 Sep 2023 | JP¥270.0b | JP¥179.3b | JP¥12.8b | 16.9x | 21.1x | 1.5x |
| Sat, 05 Aug 2023 | JP¥274.6b | JP¥179.8b | JP¥13.7b | 17.5x | 20x | 1.5x |
| Mon, 03 Jul 2023 | JP¥282.6b | JP¥178.5b | JP¥16.2b | 17.5x | 17.4x | 1.6x |
| Wed, 31 May 2023 | JP¥282.4b | JP¥178.2b | JP¥15.9b | 16.4x | 17.7x | 1.6x |
| Fri, 28 Apr 2023 | JP¥285.9b | JP¥171.9b | JP¥13.3b | 16.5x | 21.5x | 1.7x |
| Sun, 26 Mar 2023 | JP¥310.4b | JP¥171.9b | JP¥13.3b | 16.7x | 23.4x | 1.8x |
| Tue, 21 Feb 2023 | JP¥310.5b | JP¥171.6b | JP¥13.2b | 17.1x | 23.5x | 1.8x |
| Thu, 19 Jan 2023 | JP¥290.2b | JP¥166.1b | JP¥16.2b | 14.8x | 17.9x | 1.7x |
| Sat, 17 Dec 2022 | JP¥312.4b | JP¥165.5b | JP¥16.0b | 15.3x | 19.5x | 1.9x |
19.5x
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 1.28% | |
| Healthcare | -0.082% | |
| Life Sciences | -4.75% | |
| Clinical Research and Equipment | -4.75% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥1.93k | 9.0% +JP¥6.7b | 22.4% | PE17.3x | |
| 6190 PhoenixBio | JP¥547.00 | 5.4% +JP¥113.4m | 55.4% | PS1.5x | |
| 6090 Human Metabolome Technologies | JP¥660.00 | 0.3% +JP¥11.4m | 7.5% | PE19.3x |